OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
2502$0.5856

Henan Jinyuan Hydrogenated Chemicals Co Ltd

Commodity ChemicalsVerified

Henan Jinyuan Hydrogenated Chemicals Co Ltd has a market price of 0.58 CNY per share and a market cap of 554.27 million CNY, with a price-to-book ratio of 0.58 and a negative EV/EBITDA of -60.46, indicating a distressed valuation. The company's liquidity is rated as medium, with a current ratio of 1.28 and a debt-to-equity ratio of 0.3, suggesting moderate leverage. Free cash flow is negative at -53.29 million CNY, and capital expenditure is -43.22 million CNY, indicating ongoing investment in operations. Profitability is weak, with a return on equity of -3.6% and a return on assets of -2.26%, both significantly below the industry median for Commodity Chemicals. Gross profit of 30.88 million CNY and operating income of -13.96 million CNY highlight the company's struggle to maintain margins in a competitive sector. The company's net loss of 34.28 million CNY underscores the challenges in sustaining profitability. The company operates four segments: Hydrogenated Benzene-based Chemicals, Energy Products, Trading, and Others. The Hydrogenated Benzene-based Chemicals segment is the core business, supplying pure benzene, toluene, and xylene to nylon, fertilizer, and refined oil manufacturers. The Energy Products segment includes liquefied natural gas (LNG) and coal gas, while the Trading segment focuses on LNG and refined oil. The Others segment generates revenue from steam sales. Revenue concentration data is not provided, but the core chemical segment is likely the largest contributor. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. The negative net income and weak operating cash flow suggest a challenging operating environment. The company's capital structure and liquidity position indicate a need for careful management of working capital and debt obligations. The risk assessment highlights a key flag of negative net cash after subtracting total debt, signaling potential liquidity constraints. Recent events and filings have not been disclosed in the provided data, so no specific recent developments can be cited. However, the company's financial performance and risk profile suggest a need for close monitoring of its operational and financial strategies.

30-day price · 2502+0.20 (+40.8%)
Low$0.43High$0.75Close$0.69As of21 May, 00:00 UTC
Profile
CompanyHenan Jinyuan Hydrogenated Chemicals Co Ltd
Ticker2502.HK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Henan Jinyuan Hydrogenated Chemicals Co Ltd produces and sells hydrogenated benzene-based chemicals, energy products, and engages in trading of LNG and refined oil, with additional revenue from steam sales.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 0.92 confidence.

Henan Jinyuan Hydrogenated Chemicals Co Ltd has a market price of 0.58 CNY per share and a market cap of 554.27 million CNY, with a price-to-book ratio of 0.58 and a negative EV/EBITDA of -60.46, indicating a distressed valuation. The company's liquidity is rated as medium, with a current ratio of 1.28 and a debt-to-equity ratio of 0.3, suggesting moderate leverage. Free cash flow is negative at -53.29 million CNY, and capital expenditure is -43.22 million CNY, indicating ongoing investment in operations. Profitability is weak, with a return on equity of -3.6% and a return on assets of -2.26%, both significantly below the industry median for Commodity Chemicals. Gross profit of 30.88 million CNY and operating income of -13.96 million CNY highlight the company's struggle to maintain margins in a competitive sector. The company's net loss of 34.28 million CNY underscores the challenges in sustaining profitability. The company operates four segments: Hydrogenated Benzene-based Chemicals, Energy Products, Trading, and Others. The Hydrogenated Benzene-based Chemicals segment is the core business, supplying pure benzene, toluene, and xylene to nylon, fertilizer, and refined oil manufacturers. The Energy Products segment includes liquefied natural gas (LNG) and coal gas, while the Trading segment focuses on LNG and refined oil. The Others segment generates revenue from steam sales. Revenue concentration data is not provided, but the core chemical segment is likely the largest contributor. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. The negative net income and weak operating cash flow suggest a challenging operating environment. The company's capital structure and liquidity position indicate a need for careful management of working capital and debt obligations. The risk assessment highlights a key flag of negative net cash after subtracting total debt, signaling potential liquidity constraints. Recent events and filings have not been disclosed in the provided data, so no specific recent developments can be cited. However, the company's financial performance and risk profile suggest a need for close monitoring of its operational and financial strategies.
Key takeaways
  • The company is operating at a net loss with a negative return on equity and assets, indicating poor profitability.
  • Liquidity is moderate, with a current ratio of 1.28 and a debt-to-equity ratio of 0.3, but free cash flow is negative.
  • The company's core business in hydrogenated benzene-based chemicals is central to its operations, but revenue concentration data is not available.
  • Growth prospects are unclear, with no specific revenue growth projections provided.
  • The risk assessment highlights a key liquidity flag, suggesting potential challenges in managing debt obligations.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.60B
Gross profit$30.9M
Operating income-$14.0M
Net income-$34.3M
R&D
SG&A
D&A
SBC
Operating cash flow$124.4M
CapEx-$43.2M
Free cash flow-$53.3M
Total assets$1.52B
Total liabilities$565.1M
Total equity$951.1M
Cash & equivalents
Long-term debt$289.9M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.58
Market cap$554.3M
Enterprise value$844.2M
P/E
Reported non-GAAP P/E
EV/Revenue0.3
EV/Op income
EV/OCF6.8
P/B0.6
P/Tangible book0.6
Tangible book$951.1M
Net cash-$289.9M
Current ratio1.3
Debt/Equity0.3
ROA-2.3%
ROE-3.6%
Cash conversion-3.6%
CapEx/Revenue-1.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric2502Activity
Op margin-0.5%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-1.3%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin1.2%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity30.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 03:36 UTC#e0f7962e
Market quoteclose CNY 0.58 · shares 0.96B diluted
no public URL
2026-05-10 03:36 UTC#21f732bf
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 03:38 UTCJob: f98aca93